10.71
전일 마감가:
$4.59
열려 있는:
$10.7
하루 거래량:
3.83M
Relative Volume:
17.59
시가총액:
$16.69M
수익:
$8.62M
순이익/손실:
$-6.15M
주가수익비율:
-0.9711
EPS:
-11.03
순현금흐름:
$-5.32M
1주 성능:
+118.44%
1개월 성능:
+134.16%
6개월 성능:
+246.40%
1년 성능:
+87.13%
Evoke Pharma Inc Stock (EVOK) Company Profile
명칭
Evoke Pharma Inc
전화
858-345-1494
주소
420 STEVENS AVENUE, SOLANA BEACH, CA
EVOK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
EVOK
Evoke Pharma Inc
|
10.71 | 7.15M | 8.62M | -6.15M | -5.32M | -11.03 |
|
ZTS
Zoetis Inc
|
124.99 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.59 | 42.40B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.33 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.41 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
435.04 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-06-22 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2019-03-05 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2018-03-08 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2017-10-19 | 재개 | FBR & Co. | Buy |
| 2017-03-16 | 재확인 | Rodman & Renshaw | Buy |
| 2017-01-30 | 업그레이드 | Laidlaw | Neutral → Buy |
| 2017-01-05 | 업그레이드 | Rodman & Renshaw | Neutral → Buy |
| 2016-12-23 | 재확인 | Rodman & Renshaw | Neutral |
| 2016-07-19 | 재확인 | FBR Capital | Outperform |
| 2016-07-19 | 다운그레이드 | Noble Financial | Buy → Hold |
| 2016-07-18 | 다운그레이드 | Rodman & Renshaw | Buy → Neutral |
| 2016-03-16 | 개시 | Northland Capital | Outperform |
| 2016-03-14 | 재확인 | Ascendiant Capital Markets | Buy |
| 2016-02-17 | 재개 | FBR Capital | Outperform |
| 2014-12-03 | 재확인 | MLV & Co | Buy |
| 2014-11-07 | 개시 | MLV & Co | Buy |
| 2014-04-22 | 개시 | Laidlaw | Buy |
| 2013-11-19 | 개시 | Aegis Capital | Buy |
모두보기
Evoke Pharma Inc 주식(EVOK)의 최신 뉴스
[SC TO-C] Evoke Pharma Inc Tender Offer Communication | EVOK SEC FilingForm SC TO-C - Stock Titan
Gold Falls Over 1%; Uber Shares Decline After Q3 Results - Benzinga
Shareholder Alert: The Ademi Firm investigates whether Evoke Pharma Inc. is obtaining a Fair Price for its Public Shareholders - PR Newswire
Evoke Pharma Shares Skyrocket 134% After QOL Medical Announces Acquisition Deal - MSN
Evoke Pharma Rockets On Grabbing 140% Premium In Acquisition Deal - Benzinga
EVOK Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Evoke Pharma, Inc. is Fair to Shareholders - The Joplin Globe
Dow Dips Over 400 Points; Pfizer Earnings Top Estimates - Benzinga
Evoke Pharma (EVOK) Soars Over 130% on Acquisition News - GuruFocus
Why Is Evoke Pharma Stock (EVOK) Up 135% Today? - TipRanks
QOL Medical to Acquire Evoke Pharma (EVOK) at Significant Premiu - GuruFocus
QOL Medical to acquire Evoke Pharma for $11 per share in cash deal - Investing.com
Evoke Pharma enters into definitive agreement to be acquired by QOL Medical - MarketScreener
Evoke Pharma Announces Merger with QOL Medical - TipRanks
Evoke Pharma stock soars after QOL Medical acquisition announcement By Investing.com - Investing.com Philippines
Evoke Pharma stock soars after QOL Medical acquisition announcement - Investing.com
Evoke Pharma (NASDAQ: EVOK) to be acquired for $11.00/share; tender offer, closing in 2025 - Stock Titan
Candlestick signals on Evoke Pharma Inc. stock todayJuly 2025 Breakouts & Daily Volume Surge Signals - newser.com
Quantitative breakdown of Evoke Pharma Inc. recent moveSell Signal & Daily Growth Stock Investment Tips - newser.com
Evoke Pharma Inc expected to post a loss of 45 cents a shareEarnings Preview - TradingView
Using Bollinger Bands to evaluate Evoke Pharma Inc.Portfolio Value Summary & Stepwise Swing Trade Plans - newser.com
Top chart patterns to watch in Evoke Pharma Inc.2025 Top Decliners & Weekly Return Optimization Plans - newser.com
Will Evoke Pharma Inc. stock continue dividend increasesJuly 2025 Spike Watch & Daily Market Momentum Tracking - newser.com
How to read the order book for Evoke Pharma Inc.Weekly Trend Recap & Free Risk Controlled Daily Trade Plans - newser.com
Using economic indicators to assess Evoke Pharma Inc. potentialMarket Trend Summary & Smart Allocation Stock Tips - newser.com
Identifying reversal signals in Evoke Pharma Inc.July 2025 PreEarnings & Intraday High Probability Setup Alerts - newser.com
How currency fluctuations impact Evoke Pharma Inc. stockWeekly Trend Summary & Expert Verified Stock Movement Alerts - newser.com
Price action breakdown for Evoke Pharma Inc.Fed Meeting & Fast Gain Stock Tips - newser.com
Why Evoke Pharma Inc. stock is a value investor pickJuly 2025 Action & High Accuracy Trade Signal Alerts - newser.com
Will Evoke Pharma Inc. rebound enough to break evenJuly 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com
How sustainable is Evoke Pharma Inc. stock dividend payoutJuly 2025 Spike Watch & Daily Market Momentum Tracking - newser.com
Evaluating Evoke Pharma Inc. with trendline analysisJuly 2025 Fed Impact & Consistent Profit Trading Strategies - newser.com
Key metrics from Evoke Pharma Inc.’s quarterly dataDay Trade & Free Community Consensus Stock Picks - newser.com
Will Evoke Pharma Inc. stock go up soonJuly 2025 Trends & AI Powered Buy and Sell Recommendations - newser.com
What valuation multiples suggest for Evoke Pharma Inc. stock2025 Big Picture & Fast Gaining Stock Reports - newser.com
Advanced analytics toolkit walkthrough for Evoke Pharma Inc.2025 Performance Recap & Fast Entry High Yield Tips - newser.com
How Evoke Pharma Inc. stock responds to policy changesQuarterly Risk Review & Real-Time Chart Pattern Alerts - newser.com
Analyzing Evoke Pharma Inc. with risk reward ratio chartsJuly 2025 Macro Moves & AI Forecasted Stock Moves - newser.com
Custom strategy builders for tracking Evoke Pharma Inc.Market Volume Report & Real-Time Chart Breakout Alerts - newser.com
Evoke Pharma Inc (EVOK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):